Skip to main content
. 2020 Dec 12;70(10):1872–1883. doi: 10.1136/gutjnl-2020-322468

Figure 6.

Figure 6

The protective effects of bacterial-derived OGAs BtGH84 and AkkGH84 against TNBS-induced or OXA-induced colitis. (A, F) Schematic outline of the TNBS-colitis model (A), OXA-colitis model (F) and their treatment approach. (B–E, G–J) Disease severity of colitis mice: body weight change (B, G), colon length (C, H); histology manifestation on H&E staining (D, I), scale bar: 200 µm and inflammation score (E, J). Data represent the mean of three repeats per group with the SD; *P<0.05, **P<0.01, ***P<0.001. OGA, O-GlcNAcase’ OXA, oxazolone; TNBS, 2,4,6-trinitrobenzenesulfonic acid.